Climate and customer preference also matter
A randomized, placebo-controlled trial further evaluated the effect of exenatide on ICP in women with IIH [99]
According to the American Association of Clinical Endocrinologists and American College of Endocrinology (AACE/ACE) Obesity Clinical Practice Guidelines, weight loss medications should be considered as an adjunct to lifestyle therapy in all patients with T2DM as needed for weight loss sufficient to improve glycemic control, lipids, and blood pressure
A sensitive skin user might take six months to work from 0.1% to 1%, and that timeline is perfectly appropriate
Subcutaneous injection provides systemic distribution, but topical application targets specific areas of concern
Individual brain chemistry, drinking history, genetic factors, and the presence of co-occurring conditions all influence outcomes